Are Indegene latest results good or bad?

Indegene has reported its financial results for the quarter ending June 2025, showcasing a notable performance in various metrics. The company achieved net sales of Rs 760.80 crore, which is the highest quarterly figure in the last five quarters, indicating a consistent growth trend. However, the quarter-on-quarter growth in net sales was recorded at 0.69%, a decrease from the previous quarter's growth of 4.89%.
Profit Before Tax less Other Income (PBT) reached Rs 130.00 crore, marking a record high and reflecting a 20.3% increase compared to the average PBT of the previous four quarters. Nevertheless, the consolidated net profit showed a quarter-on-quarter decline of 1.02%, contrasting with a growth of 7.20% in the prior quarter.

The Profit After Tax (PAT) for the latest six months was reported at Rs 234.00 crore, which represents a year-on-year growth of 29.43%. The Operating Profit (PBDIT) also reached Rs 155.30 crore, the highest in the last five quarters, with an Operating Profit Margin of 20.41%, suggesting improved operational efficiency.

Overall, Indegene's financial performance in the June 2025 quarter reflects a positive trend in sales and profitability, reinforcing its position in the healthcare services sector. Additionally, the company saw an adjustment in its evaluation during this reporting period.